Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline

被引:34
作者
Asanad, Samuel [1 ,2 ]
Fantini, Michele [1 ,2 ,3 ]
Sultan, William [1 ]
Nassisi, Marco [1 ,4 ]
Felix, Christian M. [2 ]
Wu, Jessica [2 ]
Karanjia, Rustum [1 ,2 ,5 ,6 ]
Ross-Cisneros, Fred N. [1 ]
Sagare, Abhay P. [7 ]
Zlokovic, Berislav V. [7 ]
Chui, Helena C. [8 ]
Pogoda, Janice M. [9 ]
Arakaki, Xianghong [10 ]
Fonteh, Alfred N. [10 ]
Sadun, Alfredo A. A. A. [1 ,2 ]
Harrington, Michael G. [10 ]
机构
[1] Doheny Eye Inst, 1355 San Pablo St, Los Angeles, CA 90033 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA
[3] Univ Udine, Dept Med, Ophthalmol, Udine, Italy
[4] Univ Milan, Dept Clin Sci & Community Hlth, IRCCS Ca Granda Fdn Osped Maggiore Policlin, Ophthalmol Unit, Milan, Italy
[5] Univ Ottawa, Dept Ophthalmol, Ottawa, ON, Canada
[6] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[7] Univ Southern Calif, Dept Physiol & Neurosci, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90007 USA
[8] Univ Southern Calif, Dept Neurol, Los Angeles, CA USA
[9] Cipher Biostat Reporting, Reno, NV USA
[10] Huntington Med Res Inst, Pasadena, CA USA
来源
PLOS ONE | 2020年 / 15卷 / 05期
关键词
OPTICAL COHERENCE TOMOGRAPHY; ALZHEIMERS-DISEASE; VISUAL IMPAIRMENT; ABNORMALITIES; BIOMARKERS; LIFE;
D O I
10.1371/journal.pone.0232785
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Alzheimer's disease (AD) pathology precedes symptoms and its detection can identify at risk individuals who may benefit from early treatment. Since the retinal nerve fiber layer (RNFL) is depleted in established AD, we tested whether its thickness can predict whether cognitively healthy (CH) individuals have a normal or pathological cerebrospinal fluid (CSF) A beta(42) (A) and tau (T) ratio. Methods As part of an ongoing longitudinal study, we enrolled CH individuals, excluding those with cognitive impairment and significant ocular pathology. We classified the CH group into two sub-groups, normal (CH-NAT, n = 16) or pathological (CH-PAT, n = 27), using a logistic regression model from the CSF AT ratio that identified >85% of patients with a clinically probable AD diagnosis. Spectral-domain optical coherence tomography (OCT) was acquired for RNFL, ganglion cell-inner plexiform layer (GC-IPL), and macular thickness. Group differences were tested using mixed model repeated measures and a classification model derived using multiple logistic regression. Results Mean age (standard deviation) in the CH-PAT group (n = 27; 75.2 8.4 years) was similar (p = 0.50) to the CH-NAT group (n = 16; 74.1 7.9 years). Mean RNFL (standard error) was thinner in the CH-PAT group by 9.8 (2.7) mu m; p < 0.001. RNFL thickness classified CH-NAT vs. CH-PAT with 87% sensitivity and 56.3% specificity. Conclusions Our retinal data predict which individuals have CSF biomarkers of AD pathology before cognitive deficits are detectable with 87% sensitivity. Such results from easy-to-acquire, objective and non-invasive measurements of the RNFL merit further study of OCT technology to monitor or screen for early AD pathology.
引用
收藏
页数:13
相关论文
共 67 条
  • [1] Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don and how to move forward
    Alber, Jessica
    Goldfarb, Danielle
    Thompson, Louisa I.
    Arthur, Edmund
    Hernandez, Kimberly
    Cheng, Derrick
    DeBuc, Delia Cabrera
    Cordeiro, Francesca
    Provetti-Cunha, Leonardo
    den Haan, Jurre
    Van Stavern, Gregory P.
    Salloway, Stephen P.
    Sinoff, Stuart
    Snyder, Peter J.
    [J]. ALZHEIMERS & DEMENTIA, 2020, 16 (01) : 229 - 243
  • [2] Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease
    Alexandrov, Peter N.
    Pogue, Aileen
    Bhattacharjee, Surjyadipta
    Lukiw, Walter J.
    [J]. NEUROREPORT, 2011, 22 (12) : 623 - 627
  • [3] Correlation between cognitive impairment and retinal neural loss assessed by swept-source optical coherence tomography in patients with mild cognitive impairment
    Almeida, Ana L. M.
    Pires, Leopoldo A.
    Figueiredo, Evelyn A.
    Costa-Cunha, Luciana V. F.
    Zacharias, Leandro C.
    Preti, Rony C.
    Monteiro, Mario L. R.
    Cunha, Leonardo P.
    [J]. ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2019, 11 (01) : 659 - 669
  • [4] The Retina in Alzheimer's Disease: Histomorphometric Analysis of an Ophthalmologic Biomarker
    Asanad, Samuel
    Ross-Cisneros, Fred N.
    Nassisi, Marco
    Barron, Ernesto
    Karanjia, Rustum
    Sadun, Alfredo A.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (05) : 1491 - 1500
  • [5] Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study
    Ascaso, Francisco J.
    Cruz, Nancy
    Modrego, Pedro J.
    Lopez-Anton, Raul
    Santabarbara, Javier
    Pascual, Luis F.
    Lobo, Antonio
    Cristobal, Jose A.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 (08) : 1522 - 1530
  • [6] Batsch N.L., 2012, World Alzheimer Report 2012: Overcoming the stigma of dementia, P75
  • [7] Retinal abnormalities in early Alzheimer's disease
    Berisha, Fatmire
    Feke, Gilbert T.
    Trempe, Clement L.
    McMeel, J. Wallace
    Schepens, Charles L.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2007, 48 (05) : 2285 - 2289
  • [8] Vertebrate retina and hypothalamus development
    Byerly, Mardi S.
    Blackshaw, Seth
    [J]. WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2009, 1 (03) : 380 - 389
  • [9] Chan VTT, 2018, OPHTHALMOLOGY
  • [10] Retinal Ganglion Cell Analysis Using High-Definition Optical Coherence Tomography in Patients with Mild Cognitive Impairment and Alzheimer's Disease
    Cheung, Carol Yim-Lui
    Ong, Yi Ting
    Hilal, Saima
    Ikram, M. Kamran
    Low, Sally
    Ong, Yi Lin
    Venketasubramanian, N.
    Yap, Philip
    Seow, Dennis
    Chen, Christopher Li Hsian
    Wong, Tien Yin
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2015, 45 (01) : 45 - 56